StonvexLoading…
StonvexStonvexStonvexCore line items from VYGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $40.37M | $80.00M | $250.01M | $40.91M |
Operating Income | $-131.84M | $-83.29M | $122.01M | $-50.84M |
Net Income | $-119.72M | $-65.00M | $132.33M | $-46.41M |
EPS (Diluted) | $-2.04 | $-1.13 | $2.97 | $-1.21 |
Total Assets | $252.28M | $393.05M | $351.28M | $159.36M |
Total Liabilities | $56.20M | $93.29M | $114.96M | $100.34M |
Cash & Equivalents | $65.30M | $71.37M | $68.80M | $98.96M |
Free Cash Flow OCF − CapEx | $-135.06M | $-18.83M | $74.66M | $-15.00M |
Shares Outstanding | 59.05M | 54.73M | 44.04M | 38.61M |